X. Zhou
Oncology · with Lu · 2005–2012
A researcher in the Science corpus: 3 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 12 citations into it
Whom X. Zhou trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from X. Zhou's perspective
Ordered by how strongly the researchers X. Zhou trusts endorse each paper. Same corpus, a different order for every researcher.
- Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP (Science)
- A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells (Nature Cell Biology)
- The ErbB receptors and their role in cancer progression. (Experimental Cell Research)
- Regulation of Raf-1 by direct feedback phosphorylation. (Molecules and Cells)
- A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate
- Oncogenic kinase signalling (Nature)
- Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis (Nature)
- Centrosome aberrations: cause or consequence of cancer progression? (Nature Reviews. Cancer)
- An emerging role for PtdIns(4,5)P2-mediated signalling in human disease.
- AP-1 as a regulator of cell life and death (Nature Cell Biology)
Their papers
- Regulation of Raf-1 by direct feedback phosphorylation. (2005) — 650 citations
- Regulation of Phosphatidylinositol-5-Phosphate Signaling by Pin1 Determines Sensitivity to Oxidative Stress (2012) — 61 citations
- The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease (2007) — 688 citations